Pyoderma gangraenosum: exploring the treatment options.
Kelly
J
J
Homerton School of Health Studies, Cambridge, UK.
D000368:Aged; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001458:Bandages / Q000191:economics; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D003646:Debridement / Q000191:economics / Q000379:methods; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007814:Larva; D007871:Leg Ulcer / Q000209:etiology*; D008297:Male; D017511:Pyoderma Gangrenosum / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D017592:Skin Care / Q000191:economics / Q000379:methods; D013396:Suction / Q000191:economics / Q000379:methods; D016896:Treatment Outcome; D014945:Wound Healing
D000900:Anti-Bacterial Agents; D007166:Immunosuppressive Agents